Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d466be25a7bcade71087d1364c441de7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c13c941fbd98df6ac1246961f269990 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b09dc06fe10d815fbd44a05ae41d1b41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2a22d25c0397a81994886a8f76e4555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a566029f490c95826216024b0919f94 |
publicationDate |
2009-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20090047451-A |
titleOfInvention |
Means and Methods for Assessing Risk of Cardiac Arbitration Based on WFF-15 |
abstract |
The present invention relates to a method for identification of a subject who is subject to cardiac intervention based on the measurement of GDF-15 in a sample of a subject in need of cardiac intervention. Moreover, the present invention predicts mortality or risk of further acute cardiovascular events in patients with complications of cardiovascular disease, based on the measurement of GDF-15 and diuretic peptides and / or cardiac troponin in samples of patients with complications of cardiovascular disease. It is about a method. The invention also includes an apparatus and kit for carrying out the method described above. |
priorityDate |
2006-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |